What's the secret to living a full life? A new global survey reveals family comes first

AbbottIf you have ever asked yourself, "What makes me feel most fulfilled?" you are not alone. Nearly 2 million people recently answered that question in a new survey by Abbott, the global healthcare company. The goal of the survey was to understand what living fully means to different people and spark a conversation about happiness, health and human potential.

"We uncovered the passions and obstacles that people have as they try to live their best lives. We set out to get people talking about what it means to live fully and how they can get the most from their lives," said Elaine Leavenworth, senior vice president, chief marketing and external affairs officer, Abbott. "Ultimately, we want to help people live the fullest, healthiest life possible. Understanding more about what people value the most and what gets in their way will help us serve them better."

The survey revealed several universal truths, such as family is key to a full life and money and time are the biggest barriers. The survey also highlighted the importance of attitude. Respondents said it was the No. 1 reason why they believed others live fully.

Abbott Asked the Following Questions:

  • What is the one thing that makes you feel the most fulfilled?
  • On a scale of 1 to 100, with 1 being "not at all living fully" and 100 being "living fully," how would you rate yourself?
  • Think of a person who you believe is living fully. Why do you think they live life so well?
  • What keeps you from living your life fully?

Key Findings

  • More than 32 percent of respondents said the No. 1 key to a full life is FAMILY, followed by SUCCESS (12%); GIVING (8%) and HEALTH (7%).
  • Twenty-three percent of respondents said that ATTITUDE matters, and is the No. 1 reason people believe others are living full lives. Other key drivers were MONEY (16%), HEALTH (11%) and FAMILY (10%).
  • People said MONEY (44%) is the top barrier to living a full life, followed by TIME (33%), WORK (20%) and PRIORITIES (17%).
  • On a scale from 1 - 100 rating how fulfilled we are, the overall global median was 68.
  • When asked what they wished for their kids, more than 40 percent of people surveyed said they want GOOD HEALTH (41%), followed by GREAT ADVENTURE (29%) and CAREER SUCCESS (17%).
  • People who chose FAMILY or SPIRITUALITY as reasons why they are most fulfilled often rated themselves higher on how well they are currently "living fully." People who chose SUCCESS or MUSIC rated themselves lower on the fulfillment scale.
  • According to the survey results, the top 10 most fulfilled countries were China (79.2), Costa Rica (77.9), Colombia (76.2), Mexico (74.8), Indonesia (74.3), Thailand (72.9), Peru (72.3), Germany (71.7), Philippines (71.6) and Malaysia (69.1). The U.S. came in at 65 on the scale of living fulfilled, just a few points under the global median of 68.

"These results reflect a dynamic that has been ingrained in humans for much of history. There's always a sense of tension between what we value as society and what might actually be possible for individuals," said Eric Hedberg, Ph.D., sociologist and assistant professor, Sanford School of Social and Family Dynamics, Arizona State University. "Around the world, most societies value family and success; these are core needs of any human being. However, not every society provides the same opportunities to achieve those goals. Instead of accepting barriers to fulfillment, it's important for individuals to refocus on what they can do to change these conditions."

Other Notable Results

  • HEALTH was listed as a top three reason why people believe others are living a full life.
  • India, Philippines, Costa Rica, Puerto Rico, Peru, Argentina and France rated FAMILY as No. 1 to living fully, but those same countries also said FAMILY was a major barrier.
  • AGE and GENDER were not seen as barriers to living a full live in most countries surveyed.
  • Russia and Puerto Rico are the only two geographies to list MUSIC as a key to living fully.
  • Netherlands, Italy, Vietnam and Russia all ranked COMMUNITY at No. 4 as a top attribute to a full life.
  • Australia and France rated ADVENTURE as the second highest factor to living fully. They were the only two countries that had this answer in their top rankings.

"Living a full life begins with health. That's our belief at Abbott, and our survey found that many people around the world agree," said Leavenworth. "We hope that by inspiring people to think about what matters most to them and providing insight into ways to overcome key barriers in their lives, we will help people do more of what they love with the people they love."

From Insight to Action
Inspired by these global insights and as part of Abbott's effort to encourage others to live life fully, the global healthcare company is developing a series of tips/hacks that will help overcome some of the barriers uncovered in the global survey. These hacks will be simple, cost-effective ways to bring people together to make healthier choices, amp up their physical activity and live their best life. The tips will be backed by Abbott expert insights, science and "real world" road-testing from families worldwide.

About the Abbott Survey
Why is living fully important? It can be summed up by Abbott's mission, helping people live the best and fullest lives they can, through better health - LIFE. TO THE FULLEST. The goal of the survey was to understand what fulfillment means around the world and spark conversation about this topic. Nearly 2 million people globally participated through online surveys, social media channels and onsite events from September 2015 through March 2016. More of the global data summary can be found here.

About Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 74,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

Most Popular Now

Cannabis extract helps reset brain function in psy…

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psyc...

For first time in 40 years, cure for acute leukemi…

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has been no encouraging news for most leukemi...

New cancer treatment uses enzymes to boost immune …

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill can...

Bayer accelerates six new startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies fr...

Novartis receives European Commission approval of …

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pe...

Shire completes sale of oncology franchise

Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the...

Antioxidant reduces risk for second heart attack, …

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the A...

Novartis to divest the Sandoz US dermatology busin…

Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids po...

SOLAR-1 trial of Novartis investigational alpha-sp…

Novartis today announced the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) has met the primary endpoint s...

New tablet production facility in Ingelheim: Cente…

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on ...

Tezepelumab granted Breakthrough Therapy Designati…

AstraZeneca and its partner Amgen Inc. (Amgen) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab...

Pfizer terminates domagrozumab (PF-06252616) clini…

Pfizer Inc. (NYSE: PFE) announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrop...